Next Generation News and Research

RSS

MedVentive’s POC platform implemented at Hartford PHO

We are pleased to announce that Hartford PHO has gone live using MedVentive’s advanced clinical registries and sophisticated point of care (POC) decision support platform to help them improve the quality and coordination of patient care, promote efficiency, and support their clinical integration program.

10 Sep 2009

Peer Review Survey 2009 releases its preliminary findings

Peer review is fundamental to integration of new research findings. It allows other researchers to analyse findings and society at large to weigh up research claims. It results in 1.3 million learned articles published every year, and it is growing rapidly with the expansion of the global research community. With that growth come new concerns - about getting the next generation of researchers to review in sufficient numbers, about maintaining the system's integrity and whether it can be truly globalised; and also new ideas - about alternative quality measures, technologies to prevent plagiarism, rewarding reviewers and training them.

9 Sep 2009

Sequoia Hospital completes 1000 atrial fibrillation ablation procedures

Sequoia Hospital announced that the Cardiac Arrhythmia Program has completed 1,000 atrial fibrillation (A-Fib) ablation procedures, making it the highest total volume A-Fib ablation institution currently performing ablations in Northern and Central California.

9 Sep 2009

Neuroprosthetics 2009 national conference to focus on artificial limbs

On September 16, leaders in research and development of implantable limb neuroprosthetics will gather at Worcester Polytechnic Institute (WPI) to discuss the state of the field and to advance collaborations that will push next-generation artificial limbs and prosthetic devices closer to clinical application.

9 Sep 2009

Dr. Terry Collins offers public lecture on the growing field of green chemistry

Consumer concerns over hazardous chemicals in the air and water have led scientists to find solutions in the new field of green chemistry. "The most troubling health effects are associated with endocrine disrupting chemicals (EDCs) that may interfere with cellular development in humans and animals," says Dr. Terry Collins, a champion in the field.

9 Sep 2009

TransIT-2020 transfection reagent released by Mirus Bio

From the transfection experts, Mirus Bio introduces its next generation transfection reagent, TransIT(R)-2020 Transfection Reagent.

9 Sep 2009

Craneware reports 23% increase in revenues in the fiscal year-end results

Craneware, Inc. (AIM: CRW.L), a leader in sustainable financial improvement solutions for the U.S. healthcare market, is pleased to announce results for the year ended June 30, 2009.

9 Sep 2009

RIKEN Yokohama Institute to purchase Genetic Analysis Systems from Helicos BioSciences

Helicos BioSciences Corporation (NASDAQ:HLCS) today announced that the RIKEN Yokohama Institute Omics Science Center (OSC) has agreed to purchase four Helicos™ Genetic Analysis Systems. The transaction represents the first multisystem sale of the Helicos system to a large genome center. Shipments are expected to take place in September, with one system remaining in Cambridge to be used in a scientific collaboration between the two parties that began last year.

8 Sep 2009

rPA anthrax vaccine and its Valortim anthrax anti-toxin program data presented

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that data from the Company's third generation recombinant protective antigen (rPA) anthrax vaccine program and its Valortim((R)) anthrax anti-toxin program were presented at the Bacillus - ACT 2009 meeting, August 30 - September 3, 2009, organized by the American Society for Microbiology.

4 Sep 2009

NSF grants funds to develop next-generation nano-CT imaging system

In 1991, Ge Wang produced the first paper on spiral cone-beam computed tomography (CT), now an imaging technique used in the mainstream of the medical CT field. Today, Wang, known as a pioneer in this field, and his colleagues have been awarded more than $1.3 million from the National Science Foundation (NSF) to develop the next-generation nano-CT imaging system, which promises to greatly reduce the required dose of radiation.

4 Sep 2009

FDA approves new xTAG Cystic Fibrosis 39 Kit v2 from Luminex

Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new cystic fibrosis (CF) test: the xTAG® Cystic Fibrosis 39 Kit v2.

From Thermo Fisher Scientific Inc. 4 Sep 2009

New center to study mathematical modeling of drug resistance and internention to be established at HSPH

A new center that will focus on mathematical modeling of drug resistance, seasonal infectious diseases, and intervention allocation will be established at the Harvard School of Public Health (HSPH).

4 Sep 2009

Neuronetics raises funds to expand sales team for NeuroStar TMS Therapy

New Leaf Venture Partners (NLV Partners) announced today it has led a $30 million Series D financing round in Neuronetics, Inc., maker of NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy® for the treatment of depression.

3 Sep 2009

Abbott to acquire Visiogen for $400 million in cash

Abbott (NYSE: ABT) announced today a definitive agreement to acquire Visiogen, Inc. for $400 million in cash, providing the company with a next-generation accommodating intraocular lens (IOL) technology to address presbyopia for cataract patients.

3 Sep 2009

Monsanto sings a non-exclusive research and commercial license agreement with Cellectis

Monsanto Company (NYSE:MON) today announced a non-exclusive research and commercial license agreement with France-based Cellectis S.A. (Paris:ALCLS), a biotechnology company specialized in genome engineering, for broad use of its meganuclease technology in plants.

2 Sep 2009

GE Healthcare to develop wireless medical monitoring systems for patient care

In what would represent an important step forward in revolutionizing the way patients are monitored in the future, GE announced an initiative aimed to develop wireless medical monitoring systems, or body sensor networks (BSN), which would replace the traditional tangle of bedside cables used to capture a patient’s vital signs. GE’s vision for the systems would enable wireless monitoring from anywhere in the hospital—or even remotely from home.

2 Sep 2009

New gene therapy vector developed for transferring therapeutic DNA to a cell's nucleus

A research report featured on the cover of the September 2009 print issue of The FASEB Journal describes how Australian scientists developed a new gene therapy vector that uses the same machinery that viruses use to transport their cargo into our cells. As a result of this achievement, therapeutic DNA can be transferred to a cell's nucleus far more efficiently than in the past, raising hopes for more effective treatment of genetic disorders and some types of cancers.

1 Sep 2009